biopharma clusters 21.1.2013
TRANSCRIPT
This project is funded by
the European Union
Integrated Innovation Support
Programme
Best Practice in Biopharma Clusters and
Initiatives
Dr. Yannis Pierrakis, 21 Jan 2013
This project is funded by
the European Union Structure of the presentation
• Current Trends on Biopharma Clusters
• Clusters, data and the internet
• Case study 1: OneNucleus – Cambridge
• Case study 2: Bavarian Biotechnology Cluster
• Common features within the success stories
– How do they operate?
– How do they secure finance?
• EBR Council of European BioRegions
• Useful links
2
This project is funded by
the European Union Current Trends on Biopharma Clusters
• Companies and clusters form strategic alliances
– High uncertainty of product outcome and a heavy
reliance on R&D
– Companies are becoming increasingly unable to
conduct complete in-house R&D development
– We are seeing a growing number of strategic alliances
between pharmaceutical companies, biotechs,
academic centres and clusters
– 2800 European organisations are currenlty active in
the biopharmaceutical industry, 1050 are actively
engaging in strategic alliances with others (PharmaDeals 2006)
3
This project is funded by
the European Union Current Trends on Biopharma Clusters
Integrated Innovation
Support Programme (IISP) 4
Source: PharmaDeals 2006
This project is funded by
the European Union Leveraging efforts and resources
5
This project is funded by
the European Union
Clusters, data and the internet
6
This project is funded by
the European Union
Clusters, data and the internet
7
This project is funded by
the European Union OneNucleus – Cambridge
8
- Not for profit organisation
- A large pool of companies to support
business-to-business interaction
- Membership provides discounted entry to
events in London and Cambridge
- Economies of scale supporting the
group’s purchasing scheme
- An expanded training programme
focused on the needs of members
- Investment pitches
- Well connected with Universities and VCs
This project is funded by
the European Union OneNucleus – Cambridge
9
- Training courses (for managers and scientists,
50% subsidized for SMEs, innovation vouchers)
- Small Molecule Drug Discovery
- Introduction to Drug Development
- Introduction to Management
- Health and Safety for Representatives and
Managers
- Laboratory Health and Safety
- Commercial Awareness
- Scientific Presentation Skills
- BioProject Management
This project is funded by
the European Union OneNucleus – Cambridge
10
- Services and activities
- Collaborates with Cambridge University to
allow its Members to attend a series of
lectures on Management of Technology and
Innovation
- Available lab space
- Equipment/items for sale (including auctions
from around the world)
- Relationships with US top clusters
- Participates in EU funded projects
- Collaboration with BioMunich
This project is funded by
the European Union 5 Reasons why Cambridge is a Success
11
1. Most important has been the presence of
Cambridge University
2. Strong local industrial base has provided the
necessary general infrastructure
3. Provision of purpose-built bio-incubator
facilities
4. The entrepreneurial culture
5. The availability of venture capital funding
from London
This project is funded by
the European Union Bavarian Biotechnology Cluster
• Cluster’s objectives:
– Development of an innovation culture from education
to economy
– Supporting connections within the biotechindustry
itself as well as between local biotech companies and
global players
– Strengthening ties between research institutions and
the industry
– Advice on finance opportunities and promotion
schemes and funding programs
– Representation at the international level
12
This project is funded by
the European Union Bavarian Biotechnology Cluster
• Network Organisation and International Representation
– Development of synergy potentials and communicates
a uniform public presence
– Preparation of an annual Bavarian-wide Biotechnology
Report
– Establishment of an interactive B@B communication
portal for the networking between research and
industry
– Regular need-assessments for the regions's SMEs
13
This project is funded by
the European Union Bavarian Biotechnology Cluster
• Scouting and Technology Transfer
– Targeted scouting activities enable the transfer of
innovative technologies from research institutions to
companies and provide active support for start-ups
– Active scouting for innovative research projects with
commercialisation potential
– Establishment of Cluster Scouting Groups composed
of experts from the academic community and the
industry
– Coaching and training
14
This project is funded by
the European Union
Key driving forces of pharma/biotech
cluster
15
This project is funded by
the European Union
Common features within the success
stories
• How do they operate?
– Active networking in order to facilitate access to
knowledge, funding and equipment
– Establish collaboration with universities and
incubators
– Organise training based on their member’s
needs
– Form purchasing consortia, which through bulk
buying reduces the cost of laboratory material
purchases
16
This project is funded by
the European Union
Common features within the success
stories
• How do they operate?
– Facilitate access to VC funding
– Cluster promotion (attending trade
fairs/conferences, organising conferences,
partnering events with overseas companies,
presentations for local companies)
– Articulate needs/lobbying (interaction with local
government, interaction with national
government)
17
This project is funded by
the European Union
Common features within the success
stories
• From where do cluster organisations finance their
activities?
– Provide training at a fee (not only to cluster
members but to all interested parties)
– Subscriptions (depends on the company size e.g.
in OneNucleus starts from £165)
– Receive sponsorships (large companies,
associations)
– Activation of already existing financing schemes
– Actively involve in EU funded projects
18
This project is funded by
the European Union EBR Council of European BioRegions
• A self-financed network with over 50 biocommunities as
members across Europe and with links into clusters
around the globe (spun out from an FP6 project)
• Implementing cluster strategy
– A practical guide to developing and implementing a
cluster development strategy
• Raising visibility of cluster research facilities
– Provides examples of promotion at cluster and
individual facility level
19
This project is funded by
the European Union EBR Council of European BioRegions
• Internationalisation services
– Sharing the internationalisation tools commonly in use
in clusters across Europe
• SME self assessment tools
– An invaluable collection of websites that cluster
managers can use to support their SMEs in business
development
• Support for cluster actors
– Another extensive website section, with examples of
how cluster managers support different parts of their
biocommunity, with a strong focus on SME
development
20
This project is funded by
the European Union Useful links
• European Cluster Observatory
http://www.clusterobservatory.eu
• EBR Council of European BioRegions
http://www.cebr.net
• OneNucleus
http://www.onenucleus.com
• Cambridge Cluster Map
http://www.camclustermap.com
• Bavarian Biotechnology Cluster
http://www.biotech-bavaria.de
• Bio-Munich
http://www.bio-m.org/en
21